FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004304045> ?p ?o ?g. }

• W2004304045 endingPage "745" @default.
• W2004304045 startingPage "738" @default.
• W2004304045 abstract "Survivin, one of the apoptosis inhibitor proteins, has been detected in most cancers in humans. In addition, two splice variants (survivin-2B and survivin-deltaEx3) have been identified. The authors investigated the transcription levels of survivin messenger (m)RNA and its splice variants in nine tumor cell lines, including gliomas, and in 25 brain tumor samples, by performing quantitative reverse transcription-polymerase chain reaction. The correlation between transcript expression levels and pathological findings were also analyzed.Transcription levels were measured using primer pairs specific for survivin and either of its splice variants and were normalized to the glyceraldehyde 6-phosphate dehydrogenase. Among the tumor cell lines tested, glioblastoma cell lines showed the highest levels of survivin expression. Among brain tumor samples studied, survivin was preferentially expressed in malignant brain tumors and gliomas. The relative expression level of survivin-deltaEx3/survivin was significantly higher in malignant than in benign brain tumor samples. Expression patterns were dominant for survivin-deltaEx3 in malignant brain tumors and dominant for survivin-2B in benign ones. A significant linear correlation between survivin mRNA expression and MIB-1 labeling index was demonstrated in all brain tumor samples.The authors' results indicate that quantifying the levels of survivin and its splice variants is useful for the prediction of the cell biological malignancy of gliomas, independent of their pathological features." @default.
• W2004304045 created "2016-06-24" @default.
• W2004304045 creator A5011148041 @default.
• W2004304045 creator A5011423622 @default.
• W2004304045 creator A5023473145 @default.
• W2004304045 creator A5030580122 @default.
• W2004304045 creator A5041223334 @default.
• W2004304045 creator A5052535761 @default.
• W2004304045 creator A5070225048 @default.
• W2004304045 creator A5073338674 @default.
• W2004304045 creator A5084807068 @default.
• W2004304045 date "2003-10-01" @default.
• W2004304045 modified "2023-10-02" @default.
• W2004304045 title "Transcriptional expression of survivin and its splice variants in brain tumors in humans" @default.
• W2004304045 cites W1662899239 @default.
• W2004304045 cites W1918156452 @default.
• W2004304045 cites W1975864832 @default.
• W2004304045 cites W1979618048 @default.
• W2004304045 cites W2007612737 @default.
• W2004304045 cites W2010831478 @default.
• W2004304045 cites W2015805627 @default.
• W2004304045 cites W2035523654 @default.
• W2004304045 cites W2037875879 @default.
• W2004304045 cites W2039791984 @default.
• W2004304045 cites W2059644739 @default.
• W2004304045 cites W2072337591 @default.
• W2004304045 cites W2094985040 @default.
• W2004304045 cites W2105035331 @default.
• W2004304045 cites W2108510669 @default.
• W2004304045 cites W2154795389 @default.
• W2004304045 cites W2155523608 @default.
• W2004304045 cites W2329506722 @default.
• W2004304045 cites W4256031662 @default.
• W2004304045 doi "https://doi.org/10.3171/jns.2003.99.4.0738" @default.
• W2004304045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14567610" @default.
• W2004304045 hasPublicationYear "2003" @default.
• W2004304045 type Work @default.
• W2004304045 sameAs 2004304045 @default.
• W2004304045 citedByCount "80" @default.
• W2004304045 countsByYear W20043040452012 @default.
• W2004304045 countsByYear W20043040452013 @default.
• W2004304045 countsByYear W20043040452014 @default.
• W2004304045 countsByYear W20043040452015 @default.
• W2004304045 countsByYear W20043040452016 @default.
• W2004304045 countsByYear W20043040452017 @default.
• W2004304045 countsByYear W20043040452019 @default.
• W2004304045 countsByYear W20043040452020 @default.
• W2004304045 countsByYear W20043040452022 @default.
• W2004304045 crossrefType "journal-article" @default.
• W2004304045 hasAuthorship W2004304045A5011148041 @default.
• W2004304045 hasAuthorship W2004304045A5011423622 @default.
• W2004304045 hasAuthorship W2004304045A5023473145 @default.
• W2004304045 hasAuthorship W2004304045A5030580122 @default.
• W2004304045 hasAuthorship W2004304045A5041223334 @default.
• W2004304045 hasAuthorship W2004304045A5052535761 @default.
• W2004304045 hasAuthorship W2004304045A5070225048 @default.
• W2004304045 hasAuthorship W2004304045A5073338674 @default.
• W2004304045 hasAuthorship W2004304045A5084807068 @default.
• W2004304045 hasBestOaLocation W20043040451 @default.
• W2004304045 hasConcept C104317684 @default.
• W2004304045 hasConcept C105580179 @default.
• W2004304045 hasConcept C121608353 @default.
• W2004304045 hasConcept C126322002 @default.
• W2004304045 hasConcept C138885662 @default.
• W2004304045 hasConcept C142724271 @default.
• W2004304045 hasConcept C153911025 @default.
• W2004304045 hasConcept C179926584 @default.
• W2004304045 hasConcept C194583182 @default.
• W2004304045 hasConcept C2775975398 @default.
• W2004304045 hasConcept C2778227246 @default.
• W2004304045 hasConcept C2779130545 @default.
• W2004304045 hasConcept C2780989783 @default.
• W2004304045 hasConcept C41895202 @default.
• W2004304045 hasConcept C4692481 @default.
• W2004304045 hasConcept C502942594 @default.
• W2004304045 hasConcept C54355233 @default.
• W2004304045 hasConcept C71924100 @default.
• W2004304045 hasConcept C86803240 @default.
• W2004304045 hasConceptScore W2004304045C104317684 @default.
• W2004304045 hasConceptScore W2004304045C105580179 @default.
• W2004304045 hasConceptScore W2004304045C121608353 @default.
• W2004304045 hasConceptScore W2004304045C126322002 @default.
• W2004304045 hasConceptScore W2004304045C138885662 @default.
• W2004304045 hasConceptScore W2004304045C142724271 @default.
• W2004304045 hasConceptScore W2004304045C153911025 @default.
• W2004304045 hasConceptScore W2004304045C179926584 @default.
• W2004304045 hasConceptScore W2004304045C194583182 @default.
• W2004304045 hasConceptScore W2004304045C2775975398 @default.
• W2004304045 hasConceptScore W2004304045C2778227246 @default.
• W2004304045 hasConceptScore W2004304045C2779130545 @default.
• W2004304045 hasConceptScore W2004304045C2780989783 @default.
• W2004304045 hasConceptScore W2004304045C41895202 @default.
• W2004304045 hasConceptScore W2004304045C4692481 @default.
• W2004304045 hasConceptScore W2004304045C502942594 @default.
• W2004304045 hasConceptScore W2004304045C54355233 @default.
• W2004304045 hasConceptScore W2004304045C71924100 @default.
• W2004304045 hasConceptScore W2004304045C86803240 @default.
• W2004304045 hasIssue "4" @default.

• next